Wikidata

(Q62104975)

English

COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis

clinical trial

In more languages

Statements

title
A Phase III, 12-Week, Multicentre, Double-Blind, Randomised, Placebo- and Active Comparator-Controlled, Parallel Group Study to Investigate the Efficacy and Safety of GW406381, 5mg, 10mg, 25mg, and 50mg Administered Orally Once Daily, in Adults With Rheumatoid Arthritis (English)
0 references
sponsor
GSK
0 references
country
Argentina
0 references
Austria
0 references
Belgium
0 references
Bulgaria
0 references
Canada
0 references
Chile
0 references
Costa Rica
0 references
Denmark
0 references
Finland
0 references
France
0 references
Germany
0 references
Greece
0 references
Hungary
0 references
India
0 references
Republic of Ireland
0 references
Italy
0 references
Latvia
0 references
Mexico
0 references
Netherlands
0 references
New Zealand
0 references
Norway
0 references
Peru
0 references
Philippines
0 references
Poland
0 references
Romania
0 references
South Africa
0 references
Spain
0 references
Ukraine
0 references
United Kingdom
0 references
start time
June 2005
0 references
end time
September 2006
0 references
number of participants
2,208
0 references
research site
GSK
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62104975&oldid=2149183612"